Literature DB >> 511340

Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region.

O Weiland, J V Berg, E Bäck, P Lundbergh.   

Abstract

Six hundred and fifteen Swedish soldiers (X = 24.9 years) serving with the UN forces in Cyprus were tested for antibody against hepatitis A (anti-HAV) before and after six months' service. Before the service, a high susceptibility to hepatitis A was found, as only 2.3% (14/615) had anti-HAV. In comparison, the prevalence of anti-HAV among 124 native Cypriots (X = 23.9 years) was 97% (120/124), which showed Cyprus to be a region where hepatitis A is endemic. The soliders were given immunoglobulin (IG) prophylaxis (2 ml of 16.5% IG) against hepatitis A very third month. The incidence of subclinical seroconversion against hepatitis A among the Swedish soliders was 0.2% (1/615). It was concluded that the IG-prophylaxis scheme used seems to be highly effective and probably completely prevents even subclinical seroconversion against hepatitis A in non-immune persons in regions where hepatitis A is endemic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511340     DOI: 10.1007/bf01648930

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Protective effect of immune serum globulin (ISG) against hepatitis A infection in a natural epidemic.

Authors:  W T Hall; D L Madden; F K Mundon; D E Brandt; N A Clarke
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

2.  Limitations of commercial test for antibody to hepatitis A virus.

Authors:  J V Berg; S Bergdahl; G Lindh; P Lundbergh; R Sjöblom; O Weiland; B Flehmig
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

3.  [Antibodies against hepatitis A among Swedish blood donors].

Authors:  G Frösner; S Iwarson; A Lindholm; G Norkrans
Journal:  Lakartidningen       Date:  1978-02-15

4.  Anti-hepatitis-A antibody in Spain.

Authors:  V Vargas; R Esteban; J D Pedreira; J Viladoms; J M Hernandez; J Guardia
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321

5.  A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

Authors:  R H Purcell; D C Wong; Y Moritsugu; J L Dienstag; J A Routenberg; J D Boggs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Seroepidemiologic investigations of human hepatitis caused by A, B, and a possible third virus.

Authors:  V M Villarejos; P J Provost; O L Ittensohn; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

7.  [Frequency of hepatitis A antibodies in populations of various European countries].

Authors:  G G Frösner; H R Frösner; H Haas; K Dietz; U Sugg; W Schneider
Journal:  Schweiz Med Wochenschr       Date:  1977-02-05

8.  Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

Authors:  S M Feinstone; A Z Kapikian; R H Purceli
Journal:  Science       Date:  1973-12-07       Impact factor: 47.728

9.  Distribution of antibody to hepatitis a antigen in urban adult populations.

Authors:  W Szmuness; J L Dienstag; R H Purcell; E J Harley; C E Stevens; D C Wong
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

10.  Effect of human immune serum globulin on infectivity of hepatitis A virus.

Authors:  S Krugman
Journal:  J Infect Dis       Date:  1976-07       Impact factor: 5.226

View more
  4 in total

1.  Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus.

Authors:  A Hadjipanayis; C Hadjichristodoulou; M Kallias; K Sava; A Petsa; K Demetriadou; C Christodoulou; A Constantinou; M Sidera
Journal:  Eur J Epidemiol       Date:  1999-11       Impact factor: 8.082

2.  Hepatitis A immunity in food-handling occupations.

Authors:  D Köster; F Hofmann; H Berthold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

3.  Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.

Authors:  J D Kark
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

4.  Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.

Authors:  J D Kark; S Bar-Shany; S Shor; L Merlinski; E Nili
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.